Abstract
Primary tumors are often heterogeneous, composed of therapy-sensitive and emerging therapy-resistant cancer cells. Interestingly, treatment of therapy-sensitive tumors in heterogeneous tumor microenvironments results in apoptosis of therapy-resistant tumors. In this study, we identify a prostate apoptosis response-4 (Par-4) amino-terminal fragment (PAF) that is released by diverse therapy-sensitive cancer cells following therapy-induced caspase cleavage of the tumor suppressor Par-4 protein. PAF caused apoptosis in cancer cells resistant to therapy and inhibited tumor growth. A VASA segment of Par-4 mediated its binding and degradation by the ubiquitin ligase Fbxo45, resulting in loss of Par-4 proapoptotic function. Conversely, PAF, which contains this VASA segment, competitively bound to Fbxo45 and rescued Par-4–mediated induction of cancer cell–specific apoptosis. Collectively, our findings identify a molecular decoy naturally generated during apoptosis that inhibits a ubiquitin ligase to overcome therapy resistance in tumors.
Document Type
Article
Publication Date
8-2017
Digital Object Identifier (DOI)
https://doi.org/10.1158/0008-5472.CAN-16-1970
Funding Information
V.M. Rangnekar was recipient of NIH grants R01CA187273, R01CA165469, and R21CA179283.
Related Content
Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/).
Repository Citation
Hebbar, Nikhil; Burikhanov, Ravshan; Shukla, Nidhi; Qiu, Shirley; Zhao, Yanming; Elenitoba-Johnson, Kojo S. J.; and Rangnekar, Vivek M., "A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors" (2017). Radiation Medicine Faculty Publications. 18.
https://uknowledge.uky.edu/radmed_facpub/18
Supplementary Data
Notes/Citation Information
Published in Cancer Research, v. 77, issue 15, p. 4039-4050.
© 2017 American Association for Cancer Research
The copyright holder has granted the permission for posting the article here.
The document available for download is the authors' post-peer-review final draft of the article.